João Figueira Scarini

Dr. João Figueira Scarini

Center for Research in Immuno-oncology, Instituto de Ensino e Pesquisa do Hospital Albert Einstein, São Paulo, Brazil
orcid
DDS, Msc, PhD student

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2022 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
MSMarcelo Sperandio
Marcelo Sperandio
SWSaman Warnakulasuriya
Saman Warnakulasuriya
ASAndresa Borges Soares
Andresa Borges Soares
FPFabrício Passador‐Santos
Fabrício Passador‐Santos
FMFernanda Viviane Mariano
Fernanda Viviane Mariano
VAVera Cavalcanti de Araújo
Vera Cavalcanti de Araújo

16 March 2020 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
João Figueira ScariniJoão Figueira Scarini
João Figueira Scarini
LRLarissa Fernandes Rosa
Larissa Fernandes Rosa
RLReydson Alcides de Lima-Souza
Reydson Alcides de Lima-Souza
EEErika Said Abu Egal
Erika Said Abu Egal
ATAlfio José Tincani
Alfio José Tincani
FMFernanda Mariano
Fernanda Mariano

18 February 2022 in Oral Oncology
Verified
Journal Article
Closed access
EEErika Said Abu Egal
Erika Said Abu Egal
João Figueira ScariniJoão Figueira Scarini
João Figueira Scarini
RLReydson Alcides de Lima-Souza
Reydson Alcides de Lima-Souza
LLLuccas Lavareze
Luccas Lavareze
PFPatrícia Maria Fernandes
Patrícia Maria Fernandes
FMFernanda Viviane Mariano
Fernanda Viviane Mariano

9 January 2023 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
LLLuccas Lavareze
Luccas Lavareze
João Figueira ScariniJoão Figueira Scarini
João Figueira Scarini
RLReydson Alcides de Lima-Souza
Reydson Alcides de Lima-Souza
TKTalita de Carvalho Kimura
Talita de Carvalho Kimura
RGRogério de Oliveira Gondak
Rogério de Oliveira Gondak
FMFernanda Mariano
Fernanda Mariano

17 April 2023 in Frontiers in Oral Health
Verified
Journal Article
Open access
João Figueira ScariniJoão Figueira Scarini
João Figueira Scarini
RLReydson Alcides de Lima-Souza
Reydson Alcides de Lima-Souza
LLLuccas Lavareze
Luccas Lavareze
MAMaria Clara Falcão Ribeiro de Assis
Maria Clara Falcão Ribeiro de Assis
IDIngrid Iara Damas
Ingrid Iara Damas
FMFernanda Mariano
Fernanda Mariano
Pleomorphic adenoma (PA) is the most common salivary gland tumor, accounting for 50%–60% of these neoplasms. If untreated, 6.2% of PA may undergo malignant transformation to carcinoma ex-pleomorphic adenoma (CXPA). CXPA is a rare and aggressive malignant tumor, whose prevalence represents approximately 3%–6% of all salivary gland tumors. Although the pathogenesis of the PA-CXPA transition remains unclear, CXPA development requires the participation of cellular components and the tumor microenvironment for its progression. The extracellular matrix (ECM) comprises a heterogeneous and versatile network of macromolecules synthesized and secreted by embryonic cells. In the PA-CXPA sequence, ECM is formed by a variety of components including collagen, elastin, fibronectin, laminins, glycosaminoglycans, proteoglycans, and other glycoproteins, mainly secreted by epithelial cells, myoepithelial cells, cancer-associated fibroblasts, immune cells, and endothelial cells. Like in other tumors including breast cancer, ECM changes play an important role in the PA-CXPA sequence. This review summarizes what is currently known about the role of ECM during CXPA development.

22 January 2022 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
LLLuccas Lavareze
Luccas Lavareze
João Figueira ScariniJoão Figueira Scarini
João Figueira Scarini
RLReydson Alcides de Lima-Souza
Reydson Alcides de Lima-Souza
CECarolina Emerick
Carolina Emerick
RSRaísa Sales de Sá
Raísa Sales de Sá
FMFernanda Mariano
Fernanda Mariano